Quote:
Originally Posted by
Dan Druff
:wrong
They haven't determined this yet.
In short, there hasn't been an answer yet if the vaccine is a symptom reducer or an infection blocker:
https://www.fredhutch.org/en/news/ce...nsmission.html
It is generally believed that COVID is so dangerous because of the way the body reacts to it, not because of the virus itself. If the vaccine is simply helping the body learn to react to it properly, that's not stopping transmission. If the vaccine is actually helping the body fight the infection before it progresses into a transmissible state, then it is stopping transmission.
It is not necessarily a given that the vaccinated human body handles COVID the same way as a previously infected body would.
At this time, it's believed that either one is a realistic possibility.
Yea i know that. Now that you've written it you might accept it's true in some context for the next 2 weeks.
So you're saying it's realistic that when a vaccine has an impact on spread this conclusion would be true...
Initially vaccinating age ≥65 in Phase
1b averts approximately 0.5–2% more
deaths, compared to targeting highrisk adults or essential workers
– As before, this difference is
greatest in the scenario where
the vaccine is introduced before
incidence peaks
and
Initially vaccinating high-risk adults or
essential workers in Phase 1b averts
approximately 1–3% more infections,
compared to targeting age ≥65
– This difference is greatest in the
scenario where the vaccine is
introduced before incidence
peaks
...from only sources of science Druff accepts today. Meaning not prioritizing +65, removing nursing homes and adjusting to incidence rate we get about 0.5% more dead elders. And about 1,5% less infections.